Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.3 | 1.93 |
NAV | ₹30.32 | ₹412.51 |
Fund Started | 20 Jun 2019 | 04 Jun 1999 |
Fund Size | ₹837.41 Cr | ₹3989.42 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.3
1.93
NAV
₹30.32
₹412.51
Fund Started
20 Jun 2019
04 Jun 1999
Fund Size
₹837.41 Cr
₹3989.42 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year | 0.20% | -0.86% |
3 Year | 20.92% | 22.82% |
5 Year | 12.76% | 15.48% |
1 Year
0.20%
-0.86%
3 Year
20.92%
22.82%
5 Year
12.76%
15.48%
Equity | 98.81% | 96.59% |
Cash | 1.19% | 3.34% |
Equity
98.81%
96.59%
Cash
1.19%
3.34%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.47% |
Apollo Hospitals Enterprise Ltd. | 7.14% |
Cipla Ltd. | 6.08% |
Torrent Pharmaceuticals Ltd. | 4.71% |
JB Chemicals & Pharmaceuticals Ltd. | 4.51% |
Abbott India Ltd. | 4.48% |
Ajanta Pharma Ltd. | 4.28% |
Aurobindo Pharma Ltd. | 4.11% |
Fortis Healthcare Ltd. | 3.99% |
Lupin Ltd. | 3.94% |
Sun Pharmaceutical Industries Ltd. | 11.64% |
Divi's Laboratories Ltd. | 7.05% |
Max Healthcare Institute Ltd. | 5.24% |
Lupin Ltd. | 4.44% |
Laurus Labs Ltd. | 3.89% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Acutaas Chemicals Ltd. | 3.85% |
Cipla Ltd. | 3.79% |
Lonza Group Ag | 3.63% |
Biocon Ltd. | 3.16% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 20 Jun 2019 | 04 Jun 1999 |
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
20 Jun 2019
04 Jun 1999